Previous 10 | Next 10 |
2024-05-06 11:08:27 ET Major earnings expected before the bell on Tuesday include: BP p.l.c. ( BP ) Datadog ( DDOG ) The Walt Disney ( DIS ) Duke Energy ( DUK ) Nikola ( NKLA ) Read the full article on Seeking Alpha For further details...
2024-05-06 10:58:32 ET More on Curis Curis, Inc. (CRIS) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Curis Historical earnings data for Curis Financial information for Curis Read the full article on Seeking Alpha For...
Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024 PR Newswire LEXINGTON, Mass. , April 30, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 62.9% to $0.0373 on volume of 466,310,671 shares INVO BioScience Inc. (INVO) rose 139.5% to $1.82 on volume of 225,666,770 shares PROSHARES TRUST (SQQQ) rose 3.7% to $11.86 on volume of 167,545,988 ...
Curis, Inc. (NASDAQ: CRIS) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 26.77% on the day to $16.99. Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment ...
2024-02-09 10:15:03 ET Piper Sandler analyst issues BUY recommendation for CRIS on February 9, 2024 08:11AM ET. The previous analyst recommendation was Buy. CRIS was trading at $10.65 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curren...
2024-02-08 16:39:01 ET More on Curis Curis, Inc. (CRIS) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Curi s Read the full article on Seeking Alpha For further details see: Curis files for $300M common stock offering
2024-02-08 14:04:08 ET Curis, Inc. (CRIS) Q4 2023 Earnings Conference Call February 8, 2024 08:30 AM ET Company Participants Diantha Duvall - Chief Financial Officer Jim Dentzer - President & Chief Executive Officer Jonathan Zung - Chief Development Officer ...
2024-02-08 08:02:57 ET More on Curis Seeking Alpha’s Quant Rating on Curis Historical earnings data for Curis Financial information for Curis Read the full article on Seeking Alpha For further details see: Curis GAAP EPS of -$2.03 beats by ...
Curis Provides Fourth Quarter 2023 Business Update PR Newswire Emavusertib data presented at ASH showed 3 of 5 patients achieved CR in R/R PCNSL Expansion of clinical sites in US and Europe in progress Cash runway into 2025 Management to host confer...
News, Short Squeeze, Breakout and More Instantly...
2024-07-15 17:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Curis to Present at Upcoming Healthcare Conference in July PR Newswire LEXINGTON, Mass. , July 10, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IR...
2024-05-25 08:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...